129 related articles for article (PubMed ID: 38130019)
21. Antibodies to Both Ro52 and Ro60 for Identifying Sjögren's Syndrome Patients Best Suited for Clinical Trials of Disease-Modifying Therapies.
Armağan B; Robinson SA; Bazoberry A; Perin J; Grader-Beck T; Akpek EK; Kim J; Baer AN
Arthritis Care Res (Hoboken); 2022 Sep; 74(9):1559-1565. PubMed ID: 33742788
[TBL] [Abstract][Full Text] [Related]
22. The Sjögren's syndrome-associated autoantigen Ro52/TRIM21 modulates follicular B cell homeostasis and immunoglobulin production.
Brauner S; Ivanchenko M; Thorlacius GE; Ambrosi A; Wahren-Herlenius M
Clin Exp Immunol; 2018 Dec; 194(3):315-326. PubMed ID: 30178506
[TBL] [Abstract][Full Text] [Related]
23. Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease.
Peene I; Meheus L; De Keyser S; Humbel R; Veys EM; De Keyser F
Ann Rheum Dis; 2002 Oct; 61(10):929-33. PubMed ID: 12228166
[TBL] [Abstract][Full Text] [Related]
24. Brief Report: Patients With Primary Sjögren's Syndrome Who Are Positive for Autoantibodies to Tripartite Motif-Containing Protein 38 Show Greater Disease Severity.
Wolska N; Rybakowska P; Rasmussen A; Brown M; Montgomery C; Klopocki A; Grundahl K; Scofield RH; Radfar L; Stone DU; Anaya JM; Ice JA; Lessard CJ; Lewis DM; Rhodus NL; Gopalakrishnan R; Huang AJ; Hughes PJ; Rohrer MD; Weisman MH; Venuturupalli S; Guthridge JM; James JA; Sivils KL; Bagavant H; Deshmukh US
Arthritis Rheumatol; 2016 Mar; 68(3):724-9. PubMed ID: 26636433
[TBL] [Abstract][Full Text] [Related]
25. Latest update on the Ro/SS-A autoantibody system.
Schulte-Pelkum J; Fritzler M; Mahler M
Autoimmun Rev; 2009 Jun; 8(7):632-7. PubMed ID: 19393201
[TBL] [Abstract][Full Text] [Related]
26. Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome.
Retamozo S; Akasbi M; Brito-Zerón P; Bosch X; Bove A; Perez-de-Lis M; Jimenez I; Soto-Cardenas MJ; Gandia M; Diaz-Lagares C; Viñas O; Siso A; Perez-Alvarez R; Yague J; Ramos-Casals M
Clin Exp Rheumatol; 2012; 30(5):686-92. PubMed ID: 22704838
[TBL] [Abstract][Full Text] [Related]
27. [Antibodies against recombinant Ro 60 Kd, Ro 52 and La 48 Kd proteins in primary Sjogren's Syndrome. Utility of analytic methods combination to detect antibodies anti Ro and La].
Aguilera S; González MJ; Pérez P; Castillo D; Gatica H
Rev Med Chil; 2002 Aug; 130(8):841-9. PubMed ID: 12360791
[TBL] [Abstract][Full Text] [Related]
28. Anti-Ro60 Seropositivity Determines Anti-Ro52 Epitope Mapping in Patients With Systemic Sclerosis.
Gkoutzourelas A; Liaskos C; Mytilinaiou MG; Simopoulou T; Katsiari C; Tsirogianni A; Daoussis D; Scheper T; Meyer W; Bogdanos DP; Sakkas LI
Front Immunol; 2018; 9():2835. PubMed ID: 30581434
[TBL] [Abstract][Full Text] [Related]
29. Toll-like receptor 3 stimulation promotes Ro52/TRIM21 synthesis and nuclear redistribution in salivary gland epithelial cells, partially via type I interferon pathway.
Kyriakidis NC; Kapsogeorgou EK; Gourzi VC; Konsta OD; Baltatzis GE; Tzioufas AG
Clin Exp Immunol; 2014 Dec; 178(3):548-60. PubMed ID: 25098814
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: results of a multicentric study.
Ghillani P; André C; Toly C; Rouquette AM; Bengoufa D; Nicaise P; Goulvestre C; Gleizes A; Dragon-Durey MA; Alyanakian MA; Chretien P; Chollet-Martin S; Musset L; Weill B; Johanet C
Autoimmun Rev; 2011 Jul; 10(9):509-13. PubMed ID: 21447407
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the anti-Ro/SSA autoantibody profile between patients with primary and secondary Sjögren's syndrome.
Gál I; Lakos G; Zeher M
Autoimmunity; 2000 Sep; 32(2):89-92. PubMed ID: 11078154
[TBL] [Abstract][Full Text] [Related]
32. Isolated anti-Ro52 identifies a severe subset of Sjögren's syndrome patients.
Lee AYS; Putty T; Lin MW; Swaminathan S; Suan D; Chataway T; Thurlings RM; Gordon TP; Wang JJ; Reed JH
Front Immunol; 2023; 14():1115548. PubMed ID: 37006271
[TBL] [Abstract][Full Text] [Related]
33. The prevalence and the clinical relevance of anti-Ro52 in Korean patients with primary Sjögren's syndrome.
Song JS; Do JH; Lee SW
Rheumatol Int; 2012 Feb; 32(2):491-5. PubMed ID: 21246358
[TBL] [Abstract][Full Text] [Related]
34. Clinical Significance of Different Profiles of anti-Ro Antibodies in Connective Tissue Diseases.
Yang HT; Hong XP; Guo JW; Zhong XL; Liao R; Liu CL; Liu LX; Li K; Chen YL; Liu DZ
J Immunol Res; 2023; 2023():9195157. PubMed ID: 36741231
[TBL] [Abstract][Full Text] [Related]
35. Associations between anti-Ro52 antibodies and lung fibrosis in mixed connective tissue disease.
Gunnarsson R; El-Hage F; Aaløkken TM; Reiseter S; Lund MB; Garen T; ; Molberg Ø
Rheumatology (Oxford); 2016 Jan; 55(1):103-8. PubMed ID: 26320136
[TBL] [Abstract][Full Text] [Related]
36. IgV peptide mapping of native Ro60 autoantibody proteomes in primary Sjögren's syndrome reveals molecular markers of Ro/La diversification.
Wang JJ; Al Kindi MA; Colella AD; Dykes L; Jackson MW; Chataway TK; Reed JH; Gordon TP
Clin Immunol; 2016 Dec; 173():57-63. PubMed ID: 27609500
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of anti-Ro52-kDa/SSA (TRIM21) antibodies and associated clinical phenotype in systemic sclerosis: Data from a French cohort, a systematic review and meta-analysis.
Martel ME; Leurs A; Launay D; Behal H; Chepy A; Collet A; Sanges S; Hachulla E; Dubucquoi S; Dauchet L; Sobanski V
Autoimmun Rev; 2024 May; 23(5):103536. PubMed ID: 38555075
[TBL] [Abstract][Full Text] [Related]
38. Anti-Ro52 antibodies are a risk factor for interstitial lung disease in primary Sjögren syndrome.
Buvry C; Cassagnes L; Tekath M; Artigues M; Pereira B; Rieu V; Le Guenno G; Tournadre A; Ruivard M; Grobost V
Respir Med; 2020 Mar; 163():105895. PubMed ID: 32056839
[TBL] [Abstract][Full Text] [Related]
39. 52-kDa Ro/SSA epitopes preferentially recognized by antibodies from mothers of children with neonatal lupus and congenital heart block.
Fritsch C; Hoebeke J; Dali H; Ricchiuti V; Isenberg DA; Meyer O; Muller S
Arthritis Res Ther; 2006; 8(1):R4. PubMed ID: 16356190
[TBL] [Abstract][Full Text] [Related]
40. Anti-Ro52 and/or anti-Ro60 immune reactivity: autoantibody and disease associations.
Zampeli E; Mavrommati M; Moutsopoulos HM; Skopouli FN
Clin Exp Rheumatol; 2020; 38 Suppl 126(4):134-141. PubMed ID: 32083547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
